These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 39323282)
1. Diagnostic Performance of CLEIA Versus FEIA for KL-6 Peripheral and Alveolar Concentrations in Fibrotic Interstitial Lung Diseases: A Multicentre Study. d'Alessandro M; Gangi S; Paggi I; Soccio P; Bergantini L; Pianigiani T; Montuori G; Moriondo G; Natalello G; Marrucci S; Brogna A; Scioscia G; Lacedonia D; Cameli P; Bargagli E J Clin Lab Anal; 2024 Oct; 38(19-20):e25108. PubMed ID: 39323282 [TBL] [Abstract][Full Text] [Related]
2. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease. Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320 [TBL] [Abstract][Full Text] [Related]
3. Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease. d'Alessandro M; Conticini E; Bergantini L; Mazzei MA; Bellisai F; Selvi E; Cameli P; Frediani B; Bargagli E Tissue Cell; 2024 Oct; 90():102516. PubMed ID: 39137538 [TBL] [Abstract][Full Text] [Related]
4. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases]. Zhu C; Zhao YB; Kong LF; Li ZH; Kang J Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611 [TBL] [Abstract][Full Text] [Related]
5. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease. Ma H; Lu J; Song Y; Wang H; Yin S BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006 [TBL] [Abstract][Full Text] [Related]
6. Prognostic performance of Krebs von den Lungen-6, surfactant protein A, surfactant protein D levels in the serum and bronchoalveolar lavage fluid in chronic fibrosing interstitial pneumonia: a retrospective study. Wakamatsu K; Nagata N; Kumazoe H; Hara M; Asai S; Noda N; Kiyotani R; Fukui I; Tatsuta M; Katahira K; Akasaki T; Maki S; Miyamoto K; Otsuka J; Izumi M; Kawasaki M; Yamada H BMC Pulm Med; 2024 Aug; 24(1):404. PubMed ID: 39174992 [TBL] [Abstract][Full Text] [Related]
8. Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand? Elhai M; Avouac J; Allanore Y Semin Arthritis Rheum; 2020 Jun; 50(3):480-491. PubMed ID: 32089354 [TBL] [Abstract][Full Text] [Related]
9. Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis. Aoshima Y; Enomoto Y; Muto S; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T Lung; 2021 Jun; 199(3):289-298. PubMed ID: 33770226 [TBL] [Abstract][Full Text] [Related]
10. Expression of S100A9 and KL-6 in common interstitial lung diseases. Lin L; Zhao Y; Li Z; Li Y; Wang W; Kang J; Wang Q Medicine (Baltimore); 2022 Apr; 101(17):e29198. PubMed ID: 35512076 [TBL] [Abstract][Full Text] [Related]
11. Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review. d'Alessandro M; Bergantini L; Cameli P; Vietri L; Lanzarone N; Alonzi V; Pieroni M; M Refini R; Sestini P; Bonella F; Bargagli E Biomark Med; 2020 Jun; 14(8):665-674. PubMed ID: 32613855 [No Abstract] [Full Text] [Related]
12. Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort. Millan-Billi P; Castellví I; Martinez-Martinez L; Mariscal A; Barril S; D'Alessandro M; Franquet T; Castillo D Arch Bronconeumol; 2024 Jun; 60(6):350-355. PubMed ID: 38644152 [TBL] [Abstract][Full Text] [Related]
13. Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases. Bergantini L; d'Alessandro M; Vietri L; Rana GD; Cameli P; Acerra S; Sestini P; Bargagli E Immunol Res; 2020 Dec; 68(6):414-421. PubMed ID: 33089426 [TBL] [Abstract][Full Text] [Related]
14. BAL biomarkers' panel for differential diagnosis of interstitial lung diseases. d'Alessandro M; Carleo A; Cameli P; Bergantini L; Perrone A; Vietri L; Lanzarone N; Vagaggini C; Sestini P; Bargagli E Clin Exp Med; 2020 May; 20(2):207-216. PubMed ID: 31970550 [TBL] [Abstract][Full Text] [Related]
15. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases. Ishikawa N; Hattori N; Yokoyama A; Kohno N Respir Investig; 2012 Mar; 50(1):3-13. PubMed ID: 22554854 [TBL] [Abstract][Full Text] [Related]
16. Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP. Bennett D; Salvini M; Fui A; Cillis G; Cameli P; Mazzei MA; Fossi A; Refini RM; Rottoli P Inflammation; 2019 Apr; 42(2):463-470. PubMed ID: 30680696 [TBL] [Abstract][Full Text] [Related]
17. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study. Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437 [TBL] [Abstract][Full Text] [Related]
18. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases. Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213 [TBL] [Abstract][Full Text] [Related]
19. Serum Krebs von den Lungen-6 level as a diagnostic biomarker for interstitial lung disease in Chinese patients. Hu Y; Wang LS; Jin YP; Du SS; Du YK; He X; Weng D; Zhou Y; Li QH; Shen L; Zhang F; Su YL; Sun XL; Ding JJ; Zhang WH; Cai HR; Dai HP; Dai JH; Li HP Clin Respir J; 2017 May; 11(3):337-345. PubMed ID: 26077281 [TBL] [Abstract][Full Text] [Related]